Delivery of propellant soluble drug from a metered dose inhaler

Ashworth, H L; Wilson, C G; Sims, E E; Wotton, P K; Hardy, J G
April 1991
Thorax;Apr1991, Vol. 46 Issue 4, p245
Academic Journal
journal article
No abstract available.


Related Articles

  • Asthma: With CFC ban looming, studies find dry-powder inhalers are effective.  // Modern Medicine;Sep96, Vol. 64 Issue 9, p17 

    Reports on the findings about the effectiveness of dry-powder inhalers (DPIs) in the treatment of asthma. DPIs as alternative to chlorofluorocarbon (CFC)-propelled metered-dose inhalers (MDIs); Advantages of using DPIs; Variability and drug delivery of DPIs.

  • Inhalation Aspects of Therapeutic Aerosols. Leach, Chet L. // Toxicologic Pathology;2007, Vol. 35 Issue 1, p23 

    The pulmonary route of drug delivery can provide an excellent alternative to other routes both for local lung disease as well as systemic delivery. The year 2006 marks the 50th year since the invention of metered dose inhalers, yet inhalation is a very much underutilized route of delivery,...

  • 3M Drug Delivery Systems.  // Pharmaceutical Technology;Dec2010 Supplement, p63 

    The article presents a corporate profile of pharmaceutical company 3M Drug Delivery Systems in Saint Paul, Minnesota. It states that the company offers ingenious transdermal drug-in-adhesive, metered-dose inhaler (MDI) and CFC-free propellant pressurized metered-dose inhaler which deliver...

  • Earth-friendly inhaler targets asthma patients. Rodgers, Katie // Drug Topics;9/16/96, Vol. 140 Issue 18, p21 

    Reports on Proventil HFA (albuterol) as the first metered dose inhaler (MDI) to meet the specifications of the 1987 Montreal Protocol. Phaseout of all chlorofluorocarbon (CFC) propellants by January 1996 to stop the destruction of the earth's ozone layer; 3M Pharmaceuticals as developer of the...

  • FDA Approves New Inhaler Without CFCs.  // FDA Consumer;Jul/Aug2001, Vol. 35 Issue 4, p3 

    Reports on the approval given by the United States Food and Drug Administration to Ventolin HFA (hydroflouroalkane), a metered-dose inhaler for asthma and obstructive lung diseases. Advantage of HFA from other inhalers with chlorofluorocarbons (CFC); Effect of CFC-propelled aerosol products on...

  • Recent Development of Drug Delivery Systems for the Treatment of Asthma and Related Disorders. Takizawa, Hajime // Recent Patents on Inflammation & Allergy Drug Discovery;Nov2009, Vol. 3 Issue 3, p232 

    It is well established that airway inflammatory processes are pivotal as the pathological features of asthma. Prominent infiltration of eosinophils and Th2 lymphocytes is a hallmark of the allergic inflammation, and inhaled corticosteroids markedly suppress such inflammatory changes, resulting...

  • OLA, MDI, PEG: The Latest Words in Drug Delivery. Kube, D.M. // Drug Discovery & Development;Nov2002, Vol. 5 Issue 10, p81 

    Reports that innovative drug formulations and inhalation delivery systems expand the range of molecules that can become drugs. Constant evolution of inhalation drug delivery; Clinical benefits of the metered dose inhaler; Development of a protein microsphere drug delivery technology;...

  • Emerging Research Opportunities on Oral Inhalation Technology. Rios, Maribel // Pharmaceutical Technology;Jul2003, Vol. 27 Issue 7, p42 

    Reports on advances in formulations and inhalation systems for pulmonary delivery. Oral respiratory drug delivery systems; Inhalable insulin; Molecular and particle engineering; Pressurized metered-dose inhalers; Nebulizers; Liquid-based inhalers; Dry-powder delivery; Particle-size distribution...

  • FORMULATION AND QUALITY CONTROL OF METERED DOSE INHALER: A REVIEW. Ramteke, K. H.; Gunjal, S. S.; Sharma, Y. P. // Journal of Pharmaceutical & Scientific Innovation;Mar/Apr2012, Vol. 1 Issue 2, p44 

    The MDI is now established as the principal dosage form of inhalation drug therapy for bronchial asthma and chronic obstructive pulmonary disease (COPD). Metered dose inhalers (MDIs) are pharmaceutical delivery systems designed for oral or nasal use, which deliver discrete doses of aerosolized...

  • Capital capsules. Conlan, Michael F. // Drug Topics;4/20/98, Vol. 142 Issue 8, p37 

    Presents brief news on the United States pharmaceutical industry. Proposal regarding identifiable prescription recods; Civil penalty to be paid by CVS Corporation; Reasons for this penalty; Reference to the phase-out of chloroflourocarbon propellants in metered-dose inhalers; Number of...


Read the Article


Sign out of this library

Other Topics